AXON logo

Axon Enterprise, Inc. Stock Price

NasdaqGS:AXON Community·US$56.2b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 153 Fair Values set on narratives written by author

AXON Share Price Performance

US$715.51
294.68 (70.02%)
20.1% undervalued intrinsic discount
US$895.00
Fair Value
US$715.51
294.68 (70.02%)
26.0% undervalued intrinsic discount
US$966.54
Fair Value
Price US$715.51
AnalystHighTarget US$966.54
AnalystConsensusTarget US$884.69
AnalystLowTarget US$651.62

AXON Community Narratives

AnalystHighTarget·Updated
Fair Value US$895 20.1% undervalued intrinsic discount

Digital Transformation And Mandatory Cameras Will Expand Public Safety

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystConsensusTarget·Updated
Fair Value US$884.69 19.1% undervalued intrinsic discount

Next-generation AI And Drones Will Transform Public Safety

0users have liked this narrative
0users have commented on this narrative
78users have followed this narrative
AnalystLowTarget·Updated
Fair Value US$579.32 23.5% overvalued intrinsic discount

Rising Regulation And Pricing Pressures Will Hinder Future Performance

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Recent AXON News & Updates

If EPS Growth Is Important To You, Axon Enterprise (NASDAQ:AXON) Presents An Opportunity

Jul 15
If EPS Growth Is Important To You, Axon Enterprise (NASDAQ:AXON) Presents An Opportunity

Axon Enterprise's (NASDAQ:AXON) Returns On Capital Are Heading Higher

Jul 02
Axon Enterprise's (NASDAQ:AXON) Returns On Capital Are Heading Higher

Axon Enterprise, Inc. Key Details

US$2.4b

Revenue

US$942.8m

Cost of Revenue

US$1.4b

Gross Profit

US$1.1b

Other Expenses

US$326.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
4.16
Gross Margin
60.58%
Net Profit Margin
13.64%
Debt/Equity Ratio
73.5%

Axon Enterprise, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

High growth potential with adequate balance sheet.

2 Risks
3 Rewards

About AXON

Founded
1993
Employees
4100
CEO
Patrick Smith
WebsiteView website
www.axon.com

Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include axon officer safety plan; taser 10, taser7, taser X26P, taser X2, taser 7 CQ, and civilian series; cameras, such as axon body, axon flex, axon fleet, axon air, axon signal sidearm, axon signal vehicle, axon interview, and axon interview portable kit; software, including axon records, evidence, standards, commander, performance, auto-transcribe, justice, investigate, respond, and justice, my90, and redaction assistant; mobile applications, and training services, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. The company sells its products through its direct sales, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand bility to aggregate live video, data, and sensor feeds. It serves law enforcement, federal, correction, fire, EMS, campus, justice healthcare, retail, private security, and personal safety industries. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 0.9%
  • 3 Months: 8.7%
  • 1 Year: 18.4%
  • Year to Date: 14.8%
Over the last 7 days, the market has remained flat, although notably the Healthcare sector gained 6.4% in that time. As for the longer term, the market has risen 18% in the past 12 months. Looking forward, earnings are forecast to grow by 15% annually. Market details ›